BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12721268)

  • 41. Treatment of multiple myeloma in patients with Gaucher disease.
    Machaczka M; Lerner R; Klimkowska M; Hägglund H
    Am J Hematol; 2009 Oct; 84(10):694-6. PubMed ID: 19743447
    [No Abstract]   [Full Text] [Related]  

  • 42. Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma.
    Wavre A; Baur AS; Betz M; Mühlematter D; Jotterand M; Zaman K; Ketterer N
    Neuro Oncol; 2007 Jul; 9(3):370-2. PubMed ID: 17522337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metastatic cutaneous plasmacytoma presenting as a perianal giant mass.
    Alvarez-Twose I; Vano-Galvan S; Calvo-Villas JM; Carreter E; Piqué E; Palacios S
    Dermatol Online J; 2008 Sep; 14(9):17. PubMed ID: 19061599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testicular swelling as the presenting sign of cutaneous malignant melanoma.
    Hida T; Saga K; Ogino J; Kagaya M; Kamada A; Kaneko R; Jimbow K; Inoue R; Takahashi A
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):351-3. PubMed ID: 16503910
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical characteristics of testicular extramedullary involvement in multiple myeloma.
    Mohan M; Yarlagadda N; Szabo A; Singh A; Pina Oviedo S; Schinke C
    Am J Hematol; 2021 Mar; 96(3):E77-E81. PubMed ID: 33338289
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiple myeloma with pleural involvement.
    Badrinas F; Rodriguez-Roisin R; Rives A; Picado C
    Am Rev Respir Dis; 1974 Jul; 110(1):82-7. PubMed ID: 4834619
    [No Abstract]   [Full Text] [Related]  

  • 47. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Huston A; Brown J; Roodman GD
    Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
    [No Abstract]   [Full Text] [Related]  

  • 48. Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation.
    Sanfructuoso C; Caballero MD; Garcia-Sanz R; Vidriales B; Vazquez L; San Miguel JF
    Eur J Haematol; 1996 Mar; 56(3):181-3. PubMed ID: 8598240
    [No Abstract]   [Full Text] [Related]  

  • 49. Unusual morphologic presentation of plasma cells during the course of a multiple myeloma.
    Salignac S; Buisine J; Lesesve JF
    Haematologica; 2004 Apr; 89(4):EIM04. PubMed ID: 15075107
    [No Abstract]   [Full Text] [Related]  

  • 50. Salivary amylase-producing multiple myeloma: case report and review of the current literature.
    Sosnoff DR; Friend RB; Berkovic M; Rasansky RJ; Hoffman SM
    J Clin Oncol; 2013 Jul; 31(19):e309-11. PubMed ID: 23690421
    [No Abstract]   [Full Text] [Related]  

  • 51. Supportive therapies in the management of myeloma.
    Ludwig H;
    Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
    [No Abstract]   [Full Text] [Related]  

  • 52. Appearance of a second malignant clone associated with extramedullary spread in a case of 'smouldering' multiple myeloma.
    Majumdar G; Singh AK
    Eur J Haematol; 1989 Apr; 42(4):412-3. PubMed ID: 2597250
    [No Abstract]   [Full Text] [Related]  

  • 53. Infiltration of the spinal cord in a patient with multiple myeloma.
    Varettoni M; Corso A; Zappasodi P; Calliada F; Castagnola C; Mangiacavalli S; Lazzarino M
    J Clin Oncol; 2008 Sep; 26(25):4207-9. PubMed ID: 18757337
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pulmonary involvement in IgA multiple myeloma. A case report and review of the literature].
    Conesa Bernal C; Pascual Lledó F; Calvo Bonachera J
    Arch Bronconeumol; 1999 Jan; 35(1):54-5. PubMed ID: 10047924
    [No Abstract]   [Full Text] [Related]  

  • 55. Early response to therapy and survival in multiple myeloma.
    Schaar CG; Kluin-Nelemans JC; le Cessie S; Franck PF; te Marvelde MC; Wijermans PW
    Br J Haematol; 2004 Apr; 125(2):162-6. PubMed ID: 15059138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel agents in first-line therapy for myeloma.
    Jagannath S
    Oncology (Williston Park); 2005 Nov; 19(12):1551-4. PubMed ID: 16396150
    [No Abstract]   [Full Text] [Related]  

  • 57. Extramedullary multiple myeloma escapes the effect of thalidomide.
    Rosiñol L; Cibeira MT; Bladé J; Esteve J; Aymerich M; Rozman M; Segarra M; Cid MC; Filella X; Montserrat E
    Haematologica; 2004 Jul; 89(7):832-6. PubMed ID: 15257935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple myeloma and multiple neoplasms.
    Robins SM; Chopra D
    JAMA; 1976 Oct; 236(14):1609. PubMed ID: 989136
    [No Abstract]   [Full Text] [Related]  

  • 59. Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study.
    Offidani M; Marconi M; Corvatta L; Olivieri A; Catarini M; Leoni P
    Haematologica; 2003 Dec; 88(12):1432-3. PubMed ID: 14688003
    [No Abstract]   [Full Text] [Related]  

  • 60. [Multiple myeloma -- case report].
    Zettl F; Jung W; Schroers R
    Dtsch Med Wochenschr; 2005 Feb; 130(6):277; quiz 287-90. PubMed ID: 15692901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.